Before this system was finalized (originally around 2010 and updated in 2023), different laboratories used different terms to describe thyroid fine-needle aspiration (FNA) samples, causing confusion for clinicians. The Bethesda System was developed through an NIH-sponsored conference to create a common language.
High probability of cancer; often leads to surgery. VI: Malignant: Confirmed cancer cells. Key Benefits The Bethesda System for Reporting Thyroid Cytop...
This system is currently in its second edition (2023) and is a standard tool in cytopathology . If you'd like, I can provide: Before this system was finalized (originally around 2010
It provides clearer guidelines for indeterminate cases (III and IV), which often helped reduce unnecessary thyroidectomies. which often helped reduce unnecessary thyroidectomies.